This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Patient Advocate Foundation Launches The Heart Valve CareLine, Providing Individualized Assistance To Patients Experiencing Challenges Accessing Healthcare

The Heart Valve CareLine is now available toll-free to provide one-on-one  case management support for patients diagnosed with heart valve conditions.

HAMPTON, Va. , March 25, 2013 /PRNewswire-USNewswire/ -- Patient Advocate Foundation (PAF), a national non-profit organization with extensive experience in patient-focused case management, is pleased to launch the Heart Valve CareLine as the newest addition to its MedCareLine division thanks to a significant gift from The Edwards Lifesciences Fund.   The Heart Valve CareLine is a national, toll-free patient and provider hotline designed to provide free healthcare information and crucial case management assistance for patients who have been diagnosed with heart valve conditions. The dedicated hotline, 866-318-7892, is staffed by a team of professional case managers from PAF.

As the newest addition to PAF's MedCareLine program, the Heart Valve CareLine provides customized assistance to support people diagnosed with valvular conditions who are facing challenges with accessing the healthcare they need.   An American Heart Association survey of patients with cardiovascular disease found that more than half had difficulties paying for medical care, even though most had insurance, and 46 percent of those who had difficulty paying their medical expenses said they had delayed getting necessary care.(a)   PAF's CareLine is staffed with case managers experienced in assisting patients diagnosed with all types of heart valve conditions, and will provide help to those facing access and financial challenges in their healthcare.  The individualized support services include assistance with insurance appeals, insurance benefits and reimbursement, Medicare, Medicaid and Disability screenings, enrollments and/or denials, options for addressing medical debt crisis, as well as referrals to local, state or federal financial resources.

"Thanks to the generous commitment and support from The Edwards Lifesciences Fund, which has resulted in this extension of our MedCareLine division, heart valve patients now have a direct resource for their most complex issues and will benefit from the guidance and expertise of the professional case managers at Patient Advocate Foundation," stated PAF Founder and CEO Nancy Davenport-Ennis.

"We are passionate about helping patients and have made this pursuit our life's work," said Michael A. Mussallem, chairman and CEO of Edwards Lifesciences .   "By uniting with PAF to form the Heart Valve CareLine, we are not only providing technologies to treat patients with valvular disease, but we are also increasing access to the healthcare they need to live long, high-quality lives."  

Patients, caregivers and their providers can view a full list of services available through the Heart Valve CareLine at   or by calling the dedicated toll-free hotline at 866-318-7892.    PAF's Heart Valve CareLine case managers are available to assist Monday through Thursday from 8:00 A.M. to 8:00 P.M. and Friday from 8:00 A.M. to 7:00 P.M. Eastern Time.  

About Patient Advocate Foundation (PAF): PAF is a national non-profit organization, established in 1996, that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of financial stability relative to their diagnosis of chronic, life threatening or debilitating disease.   Patient Advocate Foundation has been consistently rated as a 4-star "exceptional" charity by Charity Navigator, the foremost independent evaluator of charities in the United States. For more information about Patient Advocate Foundation, please visit .

About Edwards Lifesciences and The Edwards Lifesciences Fund: Edwards Lifesciences (NYSE: EW) is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.   In 2004, the company established The Edwards Lifesciences Fund at the Vanguard Charitable Endowment Program to support advancements in knowledge and improvements in quality-of-life, focusing primarily upon cardiovascular disease and the communities where its employees live and work. The Fund's mission is fulfilled by making grants to qualified charitable organizations.   Additional information about the company and its Fund can be found at .

(a)    Source: American Heart Association, 2009

SOURCE Patient Advocate Foundation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.87 -0.80%
FB $117.63 -0.36%
GOOG $701.08 0.77%
TSLA $213.30 -4.20%
YHOO $36.95 2.60%


Chart of I:DJI
DOW 17,626.85 -24.41 -0.14%
S&P 500 2,051.41 +0.29 0.01%
NASDAQ 4,725.6260 -0.0130 -0.00%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs